Bank of Montreal
APRE icon

Bank of Montreal’s Aprea Therapeutics APRE Stock Holding History

Bank of Montreal’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed -$1K – 3701
2021
Q1 		$1K Sell
10
-45
-82% -$5.25K ﹤0.01% 4958
2020
Q4 		$6K Buy
55
+38
+224% +$18.1K ﹤0.01% 4733
2020
Q3 		$9K Sell
17
-12
-41% -$6.72K ﹤0.01% 4155
2020
Q2 		$18K Buy
+29
New +$19K ﹤0.01% 3888
2020
Q1 		– Sell
-41
Closed -$37K – 4081
2019
Q4 		$37K Buy
+41
New +$22.6K ﹤0.01% 3990

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Bank of Montreal's APRE Position: Q2 2021 in Review

Bank of Montreal sold out of Aprea Therapeutics (APRE) in Q2 2021, closing a stake of 10 shares — an estimated $1K sold.

Bank of Montreal first reported a position in APRE in Q4 2019 and held it in 5 quarters. The position peaked at $37K in Q4 2019. 50 funds tracked by Wall St. Rank hold APRE as of Q2 2021.

  • Bank of Montreal reported no remaining Aprea Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 10 Aprea Therapeutics shares in Q2 2021, an estimated $1K.
  • Bank of Montreal first reported a position in Aprea Therapeutics in Q4 2019 and held it in 5 quarters.
  • Bank of Montreal's Aprea Therapeutics position peaked at $37K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.